Beta Bionics (BBNX) vs Integra LifeSciences (IART)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Integra LifeSciences (IART) has outperformed Beta Bionics (BBNX) over the past year, losing 9.9% versus a loss of 18.4%. Integra LifeSciences is the larger company by market cap ($1.01 billion vs $975.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BBNX | IART |
|---|---|---|
| Share price | $18.08 | $13.00 |
| Market cap | $975.35M | $1.01B |
| 1-day change | -2.95% | -2.40% |
| YTD return | -40.66% | +4.67% |
| 1-year return | -18.37% | -9.91% |
| 5-year return | — | -80.79% |
| Forward P/E | — | 5.00 |
| EPS (TTM) | $-1.64 | $-0.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $32.71 | $20.49 |
| 52-week low | $8.80 | $8.70 |
| Distance from 52-week high | -44.73% | -36.55% |
| Average volume | 1.29M | 897.40K |
| Shares outstanding | 53.95M | 77.77M |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
BBNX vs IART FAQ
Which is bigger, Beta Bionics or Integra LifeSciences?
Integra LifeSciences (IART) is larger, with a market capitalization of $1.01B compared with $975.35M for Beta Bionics (BBNX).
Which stock has performed better over the past year, BBNX or IART?
IART returned -9.91% over the past 12 months, compared with -18.37% for BBNX (price return, excluding dividends). Past performance does not predict future results.
Are Beta Bionics and Integra LifeSciences in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.